146 related articles for article (PubMed ID: 12762348)
21. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ; Martin RJ; King TS; Boushey HA; Cherniack RM; Chinchilli VM; Craig TJ; Dolovich M; Drazen JM; Fagan JK; Fahy JV; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lazarus SC; Lemanske RF; Mauger E; Peters SP; Sorkness CA;
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[TBL] [Abstract][Full Text] [Related]
22. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM; McFarlane LC; Lipworth BJ
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[TBL] [Abstract][Full Text] [Related]
23. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
[TBL] [Abstract][Full Text] [Related]
24. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P; Shah M; Muley A
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
26. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
27. Inhaled fluticasone in asthmatic children.
Pescollderungg L; Radetti G; Gottardi E; Gentili L; Pietrobelli A; Boner AL
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):328-9; author reply 329. PubMed ID: 12269658
[No Abstract] [Full Text] [Related]
28. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
29. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[TBL] [Abstract][Full Text] [Related]
30. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[TBL] [Abstract][Full Text] [Related]
31. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
32. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR
J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
[TBL] [Abstract][Full Text] [Related]
33. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ; Clark RA; Lipworth BJ
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[TBL] [Abstract][Full Text] [Related]
34. Adrenal function and high dose inhaled corticosteroids for asthma.
Yiallouros PK; Milner AD; Conway E; Honour JW
Arch Dis Child; 1997 May; 76(5):405-10. PubMed ID: 9196354
[TBL] [Abstract][Full Text] [Related]
35. Early morning salivary cortisol and cortisone, and adrenal responses to a simplified low-dose short Synacthen test in children with asthma.
Blair J; Lancaster G; Titman A; Peak M; Newlands P; Collingwood C; Chesters C; Moorcroft T; Wallin N; Hawcutt D; Gardner C; Didi M; Lacy D; Couriel J
Clin Endocrinol (Oxf); 2014 Mar; 80(3):376-83. PubMed ID: 23895277
[TBL] [Abstract][Full Text] [Related]
36. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children.
Priftis KN; Papadimitriou A; Gatsopoulou E; Yiallouros PK; Fretzayas A; Nicolaidou P
Eur Respir J; 2006 Feb; 27(2):316-20. PubMed ID: 16452586
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
38. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
[TBL] [Abstract][Full Text] [Related]
39. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
40. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
Bisgaard H; Allen DB; Milanowski J; Kalev I; Willits L; Davies P
Pediatrics; 2004 Feb; 113(2):e87-94. PubMed ID: 14754977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
